HER2/neu Overexpression and Recurrence Risk in Early Stage Uterine Serous Carcinoma

被引：0
|
作者：
Blakaj, A. [1 ]
Jairam, V. [2 ]
Buza, N. [3 ]
Schwartz, P. [4 ]
Santin, A. [4 ]
Damast, S. [1 ]
机构：
[1] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
[2] Yale Sch Med, New Haven, CT USA
[3] Yale Sch Med, Dept Pathol, New Haven, CT USA
[4] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2018.07.139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1126
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [41] Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
    Quddus, M. Ruhul
    Hansen, Katrine
    Tantravahi, Umadevi
    Sung, C. James
    GYNECOLOGIC ONCOLOGY REPORTS, 2020, 32
  • [42] HER-2/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications
    Villella, J. A.
    Cohen, S.
    Smith, D. H.
    Hibshoosh, H.
    Hershman, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1897 - 1902
  • [43] Dual HER2 Targeting Impedes Growth of HER2 Gene-Amplified Uterine Serous Carcinoma Xenografts
    Groeneweg, Jolijn W.
    Hernandez, Silvia F.
    Byron, Virginia F.
    DiGloria, Celeste M.
    Lopez, Hector
    Scialabba, Vanessa
    Kim, Minji
    Zhang, Ling
    Borger, Darrell R.
    Tambouret, Rosemary
    Foster, Rosemary
    Rueda, Bo R.
    Growdon, Whitfield B.
    CLINICAL CANCER RESEARCH, 2014, 20 (24) : 6517 - 6528
  • [44] Overexpression/amplification of HER-2/neu is uncommon in invasive carcinoma of the uterine cervix
    Rosty, C
    Couturier, J
    Vincent-Salomon, A
    Genin, P
    Fréneaux, P
    Sigal-Zafrani, B
    Sastre-Garau, X
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (01) : 13 - 17
  • [45] HER2/NEU OVEREXPRESSION AS A PROGNOSTIC FACTOR IN UROTHELIAL CARCINOMA OF THE BLADDER: A COMPARATIVE ANALYSIS
    Pourmand, Gholamreza
    Salem, Sepehr
    Kosari, Farid
    Mehrsai, Abdolrasoul
    JOURNAL OF UROLOGY, 2011, 185 (04): : E349 - E349
  • [46] Overexpression of her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast
    Kuroda H.
    Sakamoto G.
    Ohnisi K.
    Itoyama S.
    Breast Cancer, 2004, 11 (3) : 301 - 305
  • [47] Overexpression of HER2/neu as a Prognostic Value in Iranian Women With Early Stage Breast Cancer; A Single Institute Study
    Mahyari, Hanifeh Mirtavoos
    Khosravi, Adnan
    Mahyari, Zeinab Mirtavoos
    Monfared, Zahra Esfahani
    Khosravi, Negin
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2014, 16 (11)
  • [48] HER2/neu and Ki-67 as prognostic factors in serous type ovarian carcinoma
    Dewi, I. Gusti Ayu Sri Mahendra
    Susraini, Anak Agung Ayu Ngurah
    Ekawati, Ni Putu
    BALI MEDICAL JOURNAL, 2020, 9 (02) : 567 - 571
  • [49] In vitro and in vivo activity of DHES0815A, an antibody-drug conjugate targeting HER2/neu in uterine serous carcinoma
    Tymon-Rosario, Joan
    Bonazzoli, Elena
    Guglielmi, Adele
    Bellone, Stefania
    Nagarkatti, Nupur
    Zammataro, Luca
    Zeybek, Burak
    Harold, Justin
    Mauricio, Dennis
    Clark, Mitchell
    Andikyan, Vaagn
    Huang, Gloria
    Altwerger, Gary
    Menderes, Gulden
    Azodi, Masoud
    Ratner, Elena
    Schwartz, Peter
    Santin, Alessandro
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S186 - S187
  • [50] Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma (vol 32, 100554, 2020)
    Pelligra, S.
    GYNECOLOGIC ONCOLOGY REPORTS, 2021, 35
12345